C09BB10 • verapamil + trandolapril • Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers
The combination of verapamil and trandolapril is used for the treatment of hypertension and cardiovascular diseases, particularly in patients who require both a calcium channel blocker and an angiotensin-converting enzyme (ACE) inhibitor. Verapamil is a calcium channel blocker that relaxes blood vessels and reduces heart rate, improving blood flow and lowering blood pressure. Trandolapril is an ACE inhibitor that reduces the production of angiotensin II, a hormone that causes blood vessel constriction.
This combination is administered orally, usually once daily, and the dosage is adjusted based on the patient's response and blood pressure levels. It is important for patients to adhere to the treatment and regularly monitor their blood pressure.
Common side effects include dizziness, headaches, nausea, and fatigue. In rare cases, severe adverse reactions such as severe hypotension, hyperkalemia, or allergic reactions may occur.
The combination of verapamil and trandolapril provides an effective option for managing hypertension and cardiovascular diseases, helping to reduce the risk of complications such as myocardial infarction or stroke.
Substance: verapamil + trandolapril
Date of last drug list: 01-05-2018
Commercial code: W43331001
Concentration: 180mg / 2mg
Pharmaceutical form: modified-release film-coated tablets
Quantity: 28
Product type: original
Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.